SCHEMBL827237

SCHEMBL827237

Clc1cccc2occc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.50
MAOB P27338 3/20 0.50
FTO Q9C0B1 1/20 0.50
CYP1A2 P05177 3/20 0.48
CYP2A6 P11509 3/20 0.48
FADS1 O60427 1/20 0.44
KCNA3 P22001 1/20 0.40
NR4A2 P43354 1/20 0.38
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
EED O75530 1/20 0.36
PSMB8 P28062 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.34
AHR P35869 3/20 0.33
ACHE P22303 1/20 0.33
NOS1 P29475 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28143837 0.81 MAOA (0.47) MAOAMAOBFTOCYP1A2CYP2A6
SCHEMBL30200086 0.80 CYP1A2 (0.37) MAOAMAOBFTOCYP1A2CYP2A6
SCHEMBL4215092 0.74 MAOB (0.44) MAOAMAOBFTOCYP1A2POLB
SCHEMBL13947728 0.73 MAOA (0.46) MAOAMAOBFTOCYP1A2CYP2A6
SCHEMBL275377 0.71 MAOA (0.50) MAOAMAOBFTOCYP1A2CYP2A6
SCHEMBL2008323 0.71 MAOA (0.45) MAOAMAOBFTOCYP1A2FADS1
SCHEMBL824913 0.71 CYP3A4 (0.48) MAOAMAOBFTOCYP1A2FADS1
SCHEMBL289214 0.71 MAOA (0.45) MAOAMAOBFTOCYP1A2FADS1
SCHEMBL788355 0.71 MAOA (0.45) MAOAMAOBFTOCYP1A2FADS1
SCHEMBL275378 0.71 MAOA (0.45) MAOAMAOBFTOCYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798246-A SHP2 targeting fluorescent probe, preparation method and application thereof 山东大学齐鲁医院 2025-04-11 CN claimed
CN-110305116-A A kind of Li Tasite and intermediate synthesis technology 江苏恒盛药业有限公司 2019-10-08 CN claimed
CN-119798246-A SHP2 targeting fluorescent probe, preparation method and application thereof 山东大学齐鲁医院 2025-04-11 CN disclosed
CN-117304196-A Spiro [ benzofuran-tetrahydropyrrole ] compound, preparation method and application thereof 三峡大学 2023-12-29 CN disclosed
CN-116283868-A Synthesis method of spiro [ benzofuran-cyclohexene ] compound 三峡大学 2023-06-23 CN disclosed
CN-109616572-B Light emitting device 株式会社半导体能源研究所 2023-01-17 CN disclosed
CN-110600628-B Light-emitting element, light-emitting device, display device, electronic device, and lighting device 株式会社半导体能源研究所 2022-06-14 CN disclosed
CN-112004845-B Resin composition, laminate, semiconductor wafer with resin composition layer, substrate, and semiconductor device 三菱瓦斯化学株式会社 2022-05-31 CN disclosed
CN-114315736-A Indane amine derivatives, preparation method and application thereof 甫康(上海)健康科技有限责任公司 2022-04-12 CN disclosed
CN-113880763-A Organic compound, and electronic element and electronic device using same 陕西莱特光电材料股份有限公司 2022-01-04 CN disclosed
US-11193065-B2 Liquid crystal composition, method of producing the same, and retardation film constituted from the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-12-07 US disclosed
EP-1481978-B1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST MITSUBISHI RAYON CO (JP) 2011-09-14 EP disclosed
US-20100010224-A1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST MITSUBISHI RAYON CO., LTD. (JP) 2010-01-14 US disclosed
US-7645400-B2 Composition containing carbon nanotubes having a coating MITSUBISHI RAYON CO., LTD. (JP) 2010-01-12 US disclosed
US-20090321688-A1 Carbon Nanotube Composition, Composite Having a Coated Film Composed of the Same, and Their Production Methods MITSUBISHI RAYON CO., LTD. (JP) 2009-12-31 US disclosed
US-7612218-B2 Process for production of heteroaryl-type boron compounds with iridium catalyst MITSUBISHI RAYON CO., LTD. (JP) 2009-11-03 US disclosed
US-20060052509-A1 Composition containing carbon nanotubes having coating thereof and process for producing them MITSUBISHI RAYON CO., LTD. (JP) 2006-03-09 US disclosed
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst MITSUBISHI RAYON CO., LTD. (JP) 2005-07-07 US disclosed
EP-1481978-A1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST Mitsubishi Rayon Co., Ltd. (JP) 2004-12-01 EP disclosed
JP-2000327674-A 4-HALOBENZOFURAN DERIVATIVE AND ITS PRODUCTION TOSOH CORP 2000-11-28 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100010224-A1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST PIN4, IPO5, HLCS MAOA 1125/4885MAOB 640/4885FTO 594/4885
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst PIN4, IPO5, HLCS MAOA 1125/4885MAOB 640/4885FTO 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.